{"id":472647,"date":"2021-04-07T08:03:37","date_gmt":"2021-04-07T12:03:37","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=472647"},"modified":"2021-04-07T08:03:37","modified_gmt":"2021-04-07T12:03:37","slug":"cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/","title":{"rendered":"Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed"},"content":{"rendered":"
\n

Ed Rieflin brings 19 years of leadership experience from Thoratec, St. Jude Medical and Abbott Laboratories to advance Vvital’s mitral valve solution<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

MISGAV, Israel<\/span>, April 7, 2021<\/span> \/PRNewswire\/ —\u00a0\u00a0Vvital Biomed Ltd.<\/a>(“Vvital”)<\/b>, a portfolio company of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), announced the appointment of Ed Rieflin<\/span><\/a> as Chair of the Board.<\/p>\n

Ed brings 19 years of executive leadership experience and success from Thoratec, St. Jude Medical and Abbott Laboratories, where he served as Senior Vice President of Heart Failure. Commenting on the appointment Rieflin said, “Long-term treatment solutions to mitral valve regurgitation are the holy grail of this sector. Vvital’s approach is highly promising, and I am thrilled to join the team in pursuing the development of their technology for the market.”<\/p>\n

Vvital is developing\u00a0a unique transcatheter mitral valve repair solution<\/a>\u00a0to treat and prevent recurrence\u00a0of mitral regurgitation (MR), combining two repair techniques in one procedure and with one device implant. The mitral valve leaflets repair technique, together with its “annuloplasty effect,” increases the longevity of the mitral valve leaflets regurgitation repair.<\/p>\n

Current Transcatheter Valve Repair solutions repair the valve leaflets but lack the ability to provide a long-term solution, which may lead to recurrent MR. Unlike current solutions, Vvital’s Transcatheter Mitral Valve Repair invention is appropriate for primary and secondary MR, therefore applicable to 95% of MR patients. It is performed with minimal trauma to the native valve on a beating heart.<\/p>\n

Vvital CMO, Aram Smolinsky<\/span> MD,<\/a> the heart surgeon who introduced mitral valve repair to Israel<\/span> and inventor of the Vvital solution, further elucidates, “Vvital’s procedure immediately repairs the mitral valve regurgitation. Over time, the implant is surrounded by tissue ingrowth and becomes an integral part of the native mitral valve. The implant maintains the valve’s dimensions and prevents future valve dilation and recurrent MR (annuloplasty effect).”<\/p>\n

Vvital CEO, Nir Golan<\/span><\/a> remarked, “A true industry expert, Ed Rieflin<\/span> is a great addition to our company. He will provide invaluable strategic and tactical advice to address the cardio market and further bolster the company’s capabilities in bringing its solution for mitral and tricuspid valve repair to the market.”<\/p>\n

\n Contact information:
<\/b>
\n Nir Golan<\/span>, CEO Vvital Biomed
nirg@vvital.com<\/a>
Phone: +972.54.440.7090<\/p>\n

\u00a0<\/p>\n

\n \"Cision\" View original content:http:\/\/www.prnewswire.com\/news-releases\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed-301263923.html<\/a><\/p>\n

SOURCE Vvital Biomed<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Ed Rieflin brings 19 years of leadership experience from Thoratec, St. Jude Medical and Abbott Laboratories to advance Vvital’s mitral valve solution PR Newswire MISGAV, Israel, April 7, 2021 \/PRNewswire\/ —\u00a0\u00a0Vvital Biomed Ltd.(“Vvital”), a portfolio company of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), announced the appointment of Ed Rieflin as Chair of the Board. Ed brings 19 years of executive leadership experience and success from Thoratec, St. Jude Medical and Abbott Laboratories, where he served as Senior Vice President of Heart Failure. Commenting on the appointment Rieflin said, “Long-term treatment solutions to mitral valve regurgitation are the holy grail of this sector. Vvital’s approach is highly promising, and I am thrilled to join the team in pursuing the development … <\/p>\n

Continue reading “Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-472647","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Ed Rieflin brings 19 years of leadership experience from Thoratec, St. Jude Medical and Abbott Laboratories to advance Vvital’s mitral valve solution PR Newswire MISGAV, Israel, April 7, 2021 \/PRNewswire\/ —\u00a0\u00a0Vvital Biomed Ltd.(“Vvital”), a portfolio company of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), announced the appointment of Ed Rieflin as Chair of the Board. Ed brings 19 years of executive leadership experience and success from Thoratec, St. Jude Medical and Abbott Laboratories, where he served as Senior Vice President of Heart Failure. Commenting on the appointment Rieflin said, “Long-term treatment solutions to mitral valve regurgitation are the holy grail of this sector. Vvital’s approach is highly promising, and I am thrilled to join the team in pursuing the development … Continue reading "Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-07T12:03:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN33402&sd=2021-04-07\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed\",\"datePublished\":\"2021-04-07T12:03:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\\\/\"},\"wordCount\":386,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LN33402&sd=2021-04-07\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\\\/\",\"name\":\"Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LN33402&sd=2021-04-07\",\"datePublished\":\"2021-04-07T12:03:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LN33402&sd=2021-04-07\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LN33402&sd=2021-04-07\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/","og_locale":"en_US","og_type":"article","og_title":"Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed - Market Newsdesk","og_description":"Ed Rieflin brings 19 years of leadership experience from Thoratec, St. Jude Medical and Abbott Laboratories to advance Vvital’s mitral valve solution PR Newswire MISGAV, Israel, April 7, 2021 \/PRNewswire\/ —\u00a0\u00a0Vvital Biomed Ltd.(“Vvital”), a portfolio company of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), announced the appointment of Ed Rieflin as Chair of the Board. Ed brings 19 years of executive leadership experience and success from Thoratec, St. Jude Medical and Abbott Laboratories, where he served as Senior Vice President of Heart Failure. Commenting on the appointment Rieflin said, “Long-term treatment solutions to mitral valve regurgitation are the holy grail of this sector. Vvital’s approach is highly promising, and I am thrilled to join the team in pursuing the development … Continue reading \"Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-07T12:03:37+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN33402&sd=2021-04-07","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed","datePublished":"2021-04-07T12:03:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/"},"wordCount":386,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN33402&sd=2021-04-07","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/","name":"Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN33402&sd=2021-04-07","datePublished":"2021-04-07T12:03:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN33402&sd=2021-04-07","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN33402&sd=2021-04-07"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cardio-industry-executive-ed-rieflin-appointed-to-chair-vvital-biomed\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/472647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=472647"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/472647\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=472647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=472647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=472647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}